Ikarian Capital, LLC Vir Biotechnology, Inc. Put Options Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$38.75 - $51.0 $9.69 Million - $12.8 Million
-250,000 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$26.34 - $83.07 $474,120 - $1.5 Million
-18,000 Reduced 6.72%
250,000 $12.8 Million
Q4 2020

Feb 12, 2021
BUY
$25.51 - $43.38 $6.84 Million - $11.6 Million
268,000 New
268,000 $7.18 Million

Others Institutions Holding VIR

# of Institutions
220
Shares Held
87.4M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.06B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email